No abstract available
MeSH terms
-
Benzenesulfonates / therapeutic use*
-
Brain Neoplasms / complications
-
Brain Neoplasms / drug therapy
-
Brain Neoplasms / secondary*
-
Carcinoma, Renal Cell / complications
-
Carcinoma, Renal Cell / drug therapy
-
Carcinoma, Renal Cell / secondary*
-
Cerebral Hemorrhage / epidemiology*
-
Cerebral Hemorrhage / etiology
-
France / epidemiology
-
Humans
-
Incidence
-
Kidney Neoplasms / complications*
-
Kidney Neoplasms / drug therapy
-
Kidney Neoplasms / enzymology
-
Niacinamide / analogs & derivatives
-
Phenylurea Compounds
-
Protein Kinase Inhibitors / therapeutic use*
-
Pyridines / therapeutic use*
-
Receptors, Vascular Endothelial Growth Factor / drug effects*
-
Risk Factors
-
Sorafenib
-
Treatment Outcome
Substances
-
Benzenesulfonates
-
Phenylurea Compounds
-
Protein Kinase Inhibitors
-
Pyridines
-
Niacinamide
-
Sorafenib
-
Receptors, Vascular Endothelial Growth Factor